Loading...
OTCM
LLBO
Market cap3mUSD
Jul 10, Last price  
0.00USD
1D
0.00%
1Q
40.00%
Jan 2017
-12.50%
IPO
-93.00%
Name

Lifeline Biotechnologies Inc

Chart & Performance

D1W1MN
OTCM:LLBO chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
6.74%
Rev. gr., 5y
%
Revenues
0k
65,00460,005350,00000000
Net income
-58k
L+905.24%
2,6155,937241,915-43,388-6,300-2,700-5,800-58,304
CFO
140k
+209.21%
50,181-100,80245,220139,823

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
IPO date
Jun 21, 2001
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT